Free Trial

Abrdn Life Sciences Investors (HQL) SEC Filings & 10K Form

Abrdn Life Sciences Investors logo
$13.50 +0.35 (+2.66%)
(As of 12/20/2024 04:33 PM ET)

Recent Abrdn Life Sciences Investors SEC Filings

DateFilerForm TypeView
12/20/2024
12:19 PM
Abrdn Life Sciences Investors (Issuer)
Wilson Ashton (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
12:20 PM
Abrdn Life Sciences Investors (Issuer)
Silue Kolotioloma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
10:48 AM
Abrdn Life Sciences Investors (Filer)
Form N-CEN
Annual Report for Registered Investment Companies
12/09/2024
12:05 PM
Abrdn Life Sciences Investors (Filer)
Form N-CSR
Certified shareholder report of registered management investment companies  
11/27/2024
9:59 AM
Abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
08/28/2024
1:07 PM
Abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
08/27/2024
1:46 PM
Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
9:46 AM
ABRDN ASIA-PACIFIC INCOME FUND, INC. (Filer)
ABRDN AUSTRALIA EQUITY FUND, INC. (Filer)
ABRDN EMERGING MARKETS EQUITY INCOME FUND, INC. (Filer)
abrdn Funds (Filer)
abrdn Global Dynamic Dividend Fund (Filer)
ABRDN GLOBAL INCOME FUND, INC. (Filer)
abrdn Global Infrastructure Income Fund (Filer)
abrdn Global Premier Properties Fund (Filer)
abrdn Healthcare Investors (Filer)
abrdn Healthcare Opportunities Fund (Filer)
abrdn Income Credit Strategies Fund (Filer)
ABRDN JAPAN EQUITY FUND, INC. (Filer)
Abrdn Life Sciences Investors (Filer)
abrdn National Municipal Income Fund (Filer)
abrdn Total Dynamic Dividend Fund (Filer)
abrdn World Healthcare Fund (Filer)
Form 40-17G
07/18/2024
1:56 PM
Abrdn Life Sciences Investors (Issuer)
DiMartino Rose (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
10:22 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
4:36 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
2:18 PM
Abrdn Life Sciences Investors (Issuer)
Nichols Rebecca Suzanne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
2:28 PM
Abrdn Life Sciences Investors (Issuer)
Taggart Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2024
12:59 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
1:34 PM
Abrdn Life Sciences Investors (Filer)
Form N-CSRS
06/10/2024
7:45 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:09 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
4:11 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
8:15 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
05/31/2024
2:08 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
8:13 AM
Abrdn Life Sciences Investors (Filer)
Form DEFA14A
05/23/2024
6:41 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
11:34 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
12:50 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
9:31 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:50 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
9:52 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
04/26/2024
10:40 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
7:00 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:12 PM
Abrdn Life Sciences Investors (Filer)
Form DEF 14A
04/22/2024
2:08 PM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
7:05 AM
Abrdn Life Sciences Investors (Issuer)
Saba Capital Management, L.P. (Reporting)
Weinstein Boaz (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2024
7:32 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
04/12/2024
8:20 AM
Abrdn Life Sciences Investors (Issuer)
Goetz Kathleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
11:38 AM
Abrdn Life Sciences Investors (Issuer)
Tse Loretta (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/29/2024
11:37 AM
Abrdn Life Sciences Investors (Filer)
Form NPORT-P
Monthly Portfolio Investments Report on Form NPORT
02/07/2024
6:55 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
01/12/2024
10:41 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D/A
01/04/2024
1:23 PM
Abrdn Life Sciences Investors (Issuer)
Reit Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:34 PM
Abrdn Life Sciences Investors (Issuer)
Maher Bill (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
6:54 AM
Abrdn Life Sciences Investors (Subject)
Saba Capital Management, L.P. (Filed by)
Form SC 13D
Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

Register For The Webinar To Discover
12/22/2023
1:12 PM
Abrdn Life Sciences Investors (Issuer)
Ritchie Ben (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/22/2023
1:15 PM
Abrdn Life Sciences Investors (Issuer)
Duitz Joshua (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:HQL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners